CJC-1295 & Ipamorelin

What Is CJC-1295? The Two Forms and Their Masses

UKPWritten & reviewed by William Heath · Editor, UK Peptides research library2 min readLast reviewed 2026-08-294 cited sources

The short answer

CJC-1295 is a synthetic growth-hormone-releasing hormone analogue based on the first 29 residues of human GHRH, carrying four substitutions that resist enzymatic cleavage. It exists in two forms: with a Drug Affinity Complex at 3647.2 Da, and without it at 3367.9 Da.

Key facts

Basis
GRF(1-29), residues 1-29 of human GHRH
Length
29 residues, C-terminal amide
Substitutions
D-Ala2, Gln8, Ala15, Leu27
With DAC
3647.2 Da, PubChem CID 91971820
Without DAC
3367.9 Da, CID 56841945, CAS 863288-34-0
DAC adds
279.3 Da
Developer
ConjuChem

What it is built from

Human growth-hormone-releasing hormone is 44 residues, and its biological activity resides in the first 29, the fragment known as GRF(1-29), also marketed as sermorelin. The name is written CJC-1295, CJC 1295 or cjc1295 interchangeably; the real distinction is with DAC versus without. CJC-1295 takes that fragment and substitutes four residues to slow enzymatic degradation. Despite frequent description as a 30-residue peptide, it is 29 residues terminating in an amide; PubChem's systematic name enumerates exactly 29.

The four substitutions and what each does

D-alanine at position 2 is the important one: DPP-4 cleaves after position 2 in GHRH, and a D-amino acid there is not a substrate. Gln8, Ala15 and Leu27 address other degradation points. The substitutions also remove the methionine present in native GRF(1-29), which is why Mod GRF's formula (C152H252N44O42) contains no sulfur where sermorelin's (C149H246N44O42S) does.

Research material referenced

CJC-1295 + Ipamorelin 5+5mg, third-party HPLC tested

Buy CJC-1295 + Ipamorelin · £42.99

The two forms, and the masses that separate them

With DAC, the peptide carries a maleimidopropionic acid linker that binds covalently to cysteine-34 of serum albumin, giving a half-life measured in days. Without DAC (the form usually called Modified GRF (1-29)), it clears in roughly half an hour. They differ by 279.3 Da, which is the linker. Supplying the mass alongside the name is the most reliable way to distinguish them.

Why the naming is so confused

PubChem record CID 56841945 carries both 'CJC 1295 with DAC' and 'CJC-1295-no DAC acetate' among its synonyms. The authoritative chemical database is internally inconsistent on this compound, so secondary sources inherit the confusion rather than causing it. This is why mass rather than name is the field to check.

Where it came from

CJC-1295 was developed by ConjuChem, and the DAC technology was the focus of the programme: a general approach to extending peptide half-life by covalent albumin attachment, applied here to a GHRH analogue. Teichman and colleagues reported on prolonged GH and IGF-I stimulation in healthy adults in the Journal of Clinical Endocrinology and Metabolism in 2006.

Regulatory position

CJC-1295 holds no marketing authorisation from the MHRA, EMA or FDA. Growth-hormone secretagogues are prohibited in sport under the World Anti-Doping Agency list. It is supplied here for laboratory research only.

Frequently asked questions

Is CJC-1295 29 or 30 residues?

29. GRF(1-29) means residues 1 to 29, and the peptide terminates in an amide rather than a thirtieth residue. The 30-residue description is a common error.

What is the molecular weight?

3647.2 Da with DAC, 3367.9 Da without. The 279.3 Da difference is the DAC linker.

Why do sources disagree about which form is which?

PubChem itself lists contradictory synonyms on one record. Comparing molecular weight is more reliable than comparing names.

Continue researching

Peer-reviewed guides, comparators and matched reference materials.

Primary sources & clinical trials

Peer-reviewed research and registered trials from PubMed, ClinicalTrials.gov, PubChem, FDA and NIH. All links open in a new tab and point to the primary source, so every claim can be verified at origin.

Browse the wider literature

Live database searches, not fixed citations. Results change as new work is indexed.

UKP

Written and reviewed by

William Heath · Editor, UK Peptides research library

William Heath edits the UK Peptides research library. He is responsible for what is published here: every article is sourced to primary literature, every purity or identity statement traces to a signed third-party certificate for a specific lot, and corrections are made in place with the review date updated. No scientific or medical credentials are claimed on this site; the evidence is carried by the cited sources and the certificates, not by the byline.

More CJC-1295 & Ipamorelin articles

Research use only. The information above is provided for scientific and educational reference. Compounds referenced are not approved for human use and are supplied for in vitro research or reference-material purposes only. No efficacy, safety, or therapeutic claims are made.